Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06372600
Other study ID # 2023-181
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2025
Est. completion date February 20, 2026

Study information

Verified date April 2024
Source Chengdu Sport University
Contact Chengdu Sport University Xiali Xue
Phone +86 28 8509 4700
Email 390231882@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to explore the effect of extracorporeal shock wave combined with autologous platelet-rich plasma injection on the rehabilitation of rotator cuff calcific tendinitis, to provide new treatment methods and evidence for the rehabilitation of rotator cuff calcific tendinitis, and to reduce patients; pain and return to normal life as soon as possible.


Description:

The purpose of this study is to explore the effect of extracorporeal shock wave combined with autologous platelet-rich plasma injection on the rehabilitation of rotator cuff calcific tendinitis, to provide new treatment methods and evidence for the rehabilitation of rotator cuff calcific tendinitis, and to reduce patients' pain and return to normal life as soon as possible.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date February 20, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria: - Meet the diagnostic criteria for rotator cuff calcific tendonitis, aged between 40 and 60 years old - Persistent pain in the affected shoulder, with obvious tenderness under the acromion and rotator cuff, as confirmed by X-ray and Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) examination showed one or more round-shaped high-density calcium salt deposits near the greater tuberosity of the humerus - All were diagnosed for the first time - Complaints of severe pain in the shoulder joint, obvious Exclusion Criteria: - Combined with rotator cuff trauma, long head of biceps tendonitis and other shoulder joint diseases - Past combined history of shoulder joint surgery - Patients with internal fixation of the shoulder joint - Shoulder joint combined with infection, Tumors and other lesions - Combined with severe heart, liver, and kidney dysfunction - Do not agree to participate in the study or fail to sign the informed consent form.

Study Design


Intervention

Device:
Extracorporeal shock wave therapy device
In the shoulder pain points, choose 2 to 3 of them for each treatment, apply the coupling agent, which is convenient for the treatment head to stick to the skin, and complete the longitudinal treatment and horizontal treatment. The setting frequency was 4 ~ 8 Hz, the length of the probe was 15 mm, and the pressure was set at 1.5 mJ/mm2. The frequency of each treatment point reached 2 000 ~ 2 500 times, and the hand-held pressure was set to medium-high level. A total of 6 treatments were completed. For patients with unclear pain points or regional pain, the treatment point should be supraspinatus tendon or infraspinatus tendon, and the treatment should be completed with the most severe pain site.
Biological:
Platelet-rich plasma
Autologous Platelet-rich plasma injection was performed under ultrasound guidance

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Xiali Xue

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale,VAS The full name of the Scale is Visual Analogue Scale, that is, visual analogue scale.
Minimum value and maximum value: the minimum value of the VAS scale is 0, indicating "completely painless" or "painless end"; The maximum value is 10, which indicates "the most severe pain imaginable" or "the most severe pain end." Score Significance: On the VAS scale, a higher score means a worse outcome, i.e. a greater degree of pain. The patient marks the corresponding position on the scale according to their pain experience, thus indicating the intensity of the pain.
After 1, 2, 4 and 8 weeks of intervention
Secondary American Shoulder and Elbow Surgeon's Form,ASES The full name of the scale: American Shoulder and Elbow Surgeons Score, namely, American Shoulder and Elbow Surgeons Score.
Minimum value and maximum value: The minimum value of ASES scale is 0 and the maximum value is 100.
Score Significance: On the ASES scale, a higher score means a better outcome, i.e. a better functional state of the shoulder or a milder condition.
After 1, 2, 4 and 8 weeks of intervention
Secondary the university of California at Los Angeles shoulder rating scale, UCLA Full name of the Scale: University of California at Los Angeles Shoulder Rating Scale.
Minimum and maximum values: The minimum value of the UCLA Shoulder Joint Scoring Scale is usually 0, and the maximum value may vary depending on the version and scoring rules, but a common maximum value is 35.
Score Significance: On the UCLA Shoulder Joint Rating Scale, a higher score generally means a better outcome, i.e. better shoulder function or less pain.
After 1, 2, 4 and 8 weeks of intervention
Secondary The location and size of the calcifications were examined by ultrasound After 4 and 8 weeks of intervention
See also
  Status Clinical Trial Phase
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Not yet recruiting NCT06023914 - Analysis of the Effect of Neuromuscular Electro-stimulation on the Performance of Isometric Rotator Cuff Strength. Phase 2/Phase 3
Completed NCT01984203 - Rotator Cuff Tendinopathy Exercise Trial N/A
Completed NCT01402011 - Study of 25% Dextrose Injections in Shoulder Ligaments and Tendons to Promote Their Healing N/A
Completed NCT01355549 - Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury Phase 1
Terminated NCT00764764 - Study of the Effect of Neck Treatment on Shoulder Impingement Phase 1
Completed NCT03892603 - Does The Type of Exercise Influence Outcome in Rotator Cuff Related Shoulder Pain N/A
Active, not recruiting NCT03752827 - Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears N/A
Recruiting NCT05264935 - Ultrasound-guided Lavage of Calcific Deposits of the Rotator Cuff
Recruiting NCT02967640 - Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy? Phase 2/Phase 3
Terminated NCT04115644 - Effectiveness of Corticosteroid vs. Ketorolac Shoulder Injections: A Prospective Double-Blinded Randomized Trial Phase 4
Completed NCT03425357 - Sonoelastography of the Supraspinatus Tendon N/A
Completed NCT03425344 - Discriminative Validity of Strain Elastography of the Supraspinatus Tendon N/A
Recruiting NCT04923477 - Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms N/A
Completed NCT06425913 - Effects of Cold and Kinesio Taping in Individuals With Rotator Cuff Tendonitis N/A
Completed NCT03675399 - Effect of Isometric Exercise on Pain Perception in Rotator Cuff Related Shoulder Pain N/A
Recruiting NCT05489484 - Performance and Safety Evaluation of MD-Shoulder Collagen Medical Device in the Treatment of Rotator Cuff Syndrome N/A
Recruiting NCT04094298 - Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease Phase 3
Active, not recruiting NCT03167138 - Micro-Fragmented Adipose Tissue (Lipogems®) Injection for Chronic Shoulder Pain in Persons With Spinal Cord Injury Early Phase 1
Completed NCT03567109 - Body Schema Alterations in Musculoskeletal Disorders : Effect of Laterality